167 related articles for article (PubMed ID: 33465348)
1. Enzymatically Inactive Tissue-Type Plasminogen Activator Reverses Disease Progression in the Dextran Sulfate Sodium Mouse Model of Inflammatory Bowel Disease.
Das L; Banki MA; Azmoon P; Pizzo D; Gonias SL
Am J Pathol; 2021 Apr; 191(4):590-601. PubMed ID: 33465348
[TBL] [Abstract][Full Text] [Related]
2. Tissue-type plasminogen activator selectively inhibits multiple toll-like receptors in CSF-1-differentiated macrophages.
Das L; Azmoon P; Banki MA; Mantuano E; Gonias SL
PLoS One; 2019; 14(11):e0224738. PubMed ID: 31697716
[TBL] [Abstract][Full Text] [Related]
3. Tissue-type plasminogen activator regulates macrophage activation and innate immunity.
Mantuano E; Azmoon P; Brifault C; Banki MA; Gilder AS; Campana WM; Gonias SL
Blood; 2017 Sep; 130(11):1364-1374. PubMed ID: 28684538
[TBL] [Abstract][Full Text] [Related]
4. LRP1 assembles unique co-receptor systems to initiate cell signaling in response to tissue-type plasminogen activator and myelin-associated glycoprotein.
Mantuano E; Lam MS; Gonias SL
J Biol Chem; 2013 Nov; 288(47):34009-34018. PubMed ID: 24129569
[TBL] [Abstract][Full Text] [Related]
5. Tissue-type plasminogen activator neutralizes LPS but not protease-activated receptor-mediated inflammatory responses to plasmin.
Zalfa C; Azmoon P; Mantuano E; Gonias SL
J Leukoc Biol; 2019 Apr; 105(4):729-740. PubMed ID: 30690783
[TBL] [Abstract][Full Text] [Related]
6. The LRP1/CD91 ligands, tissue-type plasminogen activator, α
Mantuano E; Azmoon P; Banki MA; Gunner CB; Gonias SL
Sci Rep; 2022 Oct; 12(1):17594. PubMed ID: 36266319
[TBL] [Abstract][Full Text] [Related]
7. PAI1 blocks NMDA receptor-mediated effects of tissue-type plasminogen activator on cell signaling and physiology.
Gonias SL; Banki MA; Gilder AS; Azmoon P; Campana WM; Mantuano E
J Cell Sci; 2018 Jul; 131(14):. PubMed ID: 29930084
[TBL] [Abstract][Full Text] [Related]
8. An antibody that targets cell-surface glucose-regulated protein-78 inhibits expression of inflammatory cytokines and plasminogen activator inhibitors by macrophages.
Gunner CB; Azmoon P; Mantuano E; Das L; Zampieri C; Pizzo SV; Gonias SL
J Cell Biochem; 2023 May; 124(5):743-752. PubMed ID: 36947703
[TBL] [Abstract][Full Text] [Related]
9. Plasminogen activator receptor assemblies in cell signaling, innate immunity, and inflammation.
Gonias SL
Am J Physiol Cell Physiol; 2021 Oct; 321(4):C721-C734. PubMed ID: 34406905
[TBL] [Abstract][Full Text] [Related]
10. Platelet activating factor receptor acts to limit colitis-induced liver inflammation.
Liu G; Baird AW; Parsons MJ; Fan K; Skerrett-Byrne DA; Nair PM; Makanyengo S; Chen J; Neal R; Goggins BJ; Tay H; Mathe A; Soh WS; Minahan K; Hansbro PM; Nixon B; McCaughan GW; Holtmann G; Colgan SP; Keely S
FASEB J; 2020 Jun; 34(6):7718-7732. PubMed ID: 32293760
[TBL] [Abstract][Full Text] [Related]
11. The role of transient receptor potential vanilloid 1 (TRPV1) receptors in dextran sulfate-induced colitis in mice.
Szitter I; Pozsgai G; Sandor K; Elekes K; Kemeny A; Perkecz A; Szolcsanyi J; Helyes Z; Pinter E
J Mol Neurosci; 2010 Sep; 42(1):80-8. PubMed ID: 20411352
[TBL] [Abstract][Full Text] [Related]
12. The NMDA receptor functions independently and as an LRP1 co-receptor to promote Schwann cell survival and migration.
Mantuano E; Lam MS; Shibayama M; Campana WM; Gonias SL
J Cell Sci; 2015 Sep; 128(18):3478-88. PubMed ID: 26272917
[TBL] [Abstract][Full Text] [Related]
13. The functional role of the second NPXY motif of the LRP1 beta-chain in tissue-type plasminogen activator-mediated activation of N-methyl-D-aspartate receptors.
Martin AM; Kuhlmann C; Trossbach S; Jaeger S; Waldron E; Roebroek A; Luhmann HJ; Laatsch A; Weggen S; Lessmann V; Pietrzik CU
J Biol Chem; 2008 May; 283(18):12004-13. PubMed ID: 18321860
[TBL] [Abstract][Full Text] [Related]
14. MyD88-deficient mice develop severe intestinal inflammation in dextran sodium sulfate colitis.
Araki A; Kanai T; Ishikura T; Makita S; Uraushihara K; Iiyama R; Totsuka T; Takeda K; Akira S; Watanabe M
J Gastroenterol; 2005 Jan; 40(1):16-23. PubMed ID: 15692785
[TBL] [Abstract][Full Text] [Related]
15. Exacerbated intestinal inflammation in P2Y
Salem M; El Azreq MA; Pelletier J; Robaye B; Aoudjit F; Sévigny J
Biochim Biophys Acta Mol Basis Dis; 2019 Oct; 1865(10):2595-2605. PubMed ID: 31271845
[TBL] [Abstract][Full Text] [Related]
16. Intestinal Epithelial Cell-specific Deletion of Cytokine-inducible SH2-containing Protein Alleviates Experimental Colitis in Ageing Mice.
Hu X; Jiao F; Deng J; Zhou Z; Chen S; Liu C; Liu Z; Guo F
J Crohns Colitis; 2023 Aug; 17(8):1278-1290. PubMed ID: 36881790
[TBL] [Abstract][Full Text] [Related]
17. MD-1 deficiency attenuates dextran sodium sulfate (DSS)-induced colitis through modulating the function of colonic lamina propria dendritic cells.
Pan H; Zhang G; Zhang L; Wang W; Shang J; Wang X; Zhao Q; Li J
Mol Immunol; 2016 Jul; 75():1-10. PubMed ID: 27209086
[TBL] [Abstract][Full Text] [Related]
18. Inhibitor of apoptosis-stimulating p53 protein protects against inflammatory bowel disease in mice models by inhibiting the nuclear factor kappa B signaling.
Qian K; Yuan L; Wang S; Kuang Y; Jin Q; Long D; Jiang Y; Zhao H; Liu K; Yao H
Clin Exp Immunol; 2021 Aug; 205(2):246-256. PubMed ID: 33942299
[TBL] [Abstract][Full Text] [Related]
19. Effects of intra-abdominal administration of recombinant tissue plasminogen activator on coagulation, fibrinolysis and inflammatory responses in experimental polymicrobial peritonitis.
van Veen SQ; Meijers JC; Levi M; van Gulik TM; Boermeester MA
Shock; 2007 May; 27(5):534-41. PubMed ID: 17438459
[TBL] [Abstract][Full Text] [Related]
20. Tissue and urokinase plasminogen activators instigate the degeneration of retinal ganglion cells in a mouse model of glaucoma.
Chintala SK
Exp Eye Res; 2016 Feb; 143():17-27. PubMed ID: 26474495
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
